Back to today’s briefing

Story perspectives

Health Canada Approves Needle-Free Epinephrine Spray Neffy

4/16/2026

30 5 Full Breakdown

Summary

Story summary

Health Canada approved Neffy, a 2 mg needle-free epinephrine nasal spray by ALK Canada for adults and children over 30 kilograms, with availability this summer.
Neffy was approved in the U.S. in 2024, where a 1 mg dose is available for lighter children, and Dr. Mariam Hanna of McMaster University says non-needle delivery may encourage timely use.
The pocket-sized spray has a 30-month shelf life.

1 of 1

Story summary

Health Canada approved Neffy, a 2 mg needle-free epinephrine nasal spray by ALK Canada for adults and children over 30 kilograms, with availability this summer.
Neffy was approved in the U.S. in 2024, where a 1 mg dose is available for lighter children, and Dr. Mariam Hanna of McMaster University says non-needle delivery may encourage timely use.
The pocket-sized spray has a 30-month shelf life.